Contact us to discuss your strategic partnering needs
bit.bio offers partnering opportunities that affords access to the most relevant parental human cell types and corresponding disease models.
These models are physiologically relevant, phenotypically characterised, offering predictive, in vitro, human cells for drug screening, toxicity testing, regenerative medicine, and tissue engineering applications.
Why partner with us?
Consistent cells at scale
Whether you need human cells in small batches or greater than a billion cells, quantity requirements can be specified to meet experimental needs using bit.bio’s wild type cells and/or disease models
Guaranteed batch delivery
bit.bio offers blanket order options to provide recurring delivery of specific cells when you need them
Custom disease models
bit.bio can create advanced human cell disease models by introducing or removing disease-causing mutations and/or associated reporter technologies into any bit.bio wild type cell type